
Omar Nass MD
Cardiac Electrophysiology, Heart Failure & Transplantation
Physician
Join to view full profile
7440 S 91st StLincoln, NE 68526
Phone+1 402-489-6555
Fax+1 402-328-3770
Dr. Nass is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Henry Ford Health/Henry Ford HospitalFellowship, Cardiovascular Disease, 1995 - 1998
Henry Ford Health/Henry Ford HospitalResidency, Internal Medicine, 1991 - 1995
Damascus University Faculty of MedicineClass of 1989
Certifications & Licensure
FL State Medical License 2023 - 2028
NE State Medical License 2006 - 2024
IA State Medical License 2010 - 2022
IL State Medical License 2004 - 2008
MT State Medical License 2000 - 2005
MI State Medical License 1993 - 2001
American Board of Internal Medicine Advanced Heart Failure and Transplant Cardiology
American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2013-2014
- CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2012-2013
- Fellow (FACC) American College of Cardiology
Publications & Presentations
PubMed
- 7 citationsLong-term Pharmacological Activation of PPARγDoes not Prevent Left Ventricular Remodeling in Dogs with Advanced Heart FailureGeorge Suzuki, Sanjaya Khanal, Sharad Rastogi, Hideaki Morita, Takayuki Mishima
Cardiovascular Drugs and Therapy. 2007-02-09 - 9 citationsEffects of the AT1-receptor antagonist eprosartan on the progression of left ventricular dysfunction in dogs with heart failure.George Suzuki, Takayuki Mishima, Elaine J. Tanhehco, Victor G. Sharov, Anastassia Todor
British Journal of Pharmacology. 2003-01-01 - 109 citationsRanolazine, a partial fatty acid oxidation (pFOX) inhibitor, improves left ventricular function in dogs with chronic heart failure * **Hani N. Sabbah, Margaret P. Chandler, Takayuki Mishima, George Suzuki, Pervaiz A. Chaudhry
Journal of Cardiac Failure. 2002-12-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









